At 78.1x trailing earnings, CMPR screens optically expensive, but the 17.2 forward P/E tells you the market expects a dramatic earnings normalization. The compression from 78.1 to 17.2 alongside a 1.4 forward PEG implies growth is anticipated but not explosively priced in. However, the balance sheet is not fortress-like: a 2.6 Altman Z-Score places the company in a gray zone rather than distress, yet it does not offer strong downside protection. With a 0.5 Price/Sales multiple and a 10.90% ROIC, the market appears skeptical of sustainability, not blind to value—this is a transitional story priced for recovery, not a clear mispricing screaming deep value.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.